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Abstract 
African swine fever (ASF) is a pathology of pigs against which there is no treatment or vaccine. Understanding the 
equilibrium between innate and adaptive protective responses and immune pathology might contribute to the 
development of strategies against ASFV. Here we compare, using a proteomic approach, the course of the in vivo 
infection caused by two homologous strains: the virulent E75 and the attenuated E75CV1. Our results show a progres‑
sive loss of proteins by day 7 post‑infection (pi) with E75, reflecting tissue destruction. Many signal pathways were 
affected by both infections but in different ways and extensions. Cytoskeletal remodelling and clathrin‑endocytosis 
were affected by both isolates, while a greater number of proteins involved on inflammatory and immunological 
pathways were altered by E75CV1. 14‑3‑3 mediated signalling, related to immunity and apoptosis, was inhibited 
by both isolates. The implication of the Rho GTPases by E75CV1 throughout infection is also evident. Early events 
reflected the lack of E75 recognition by the immune system, an evasion strategy acquired by the virulent strains, and 
significant changes at 7 days post‑infection (dpi), coinciding with the peak of infection and the time of death. The 
protein signature at day 31 pi with E75CV1 seems to reflect events observed at 1 dpi, including the upregulation of 
proteosomal subunits and molecules described as autoantigens (vimentin, HSPB1, enolase and lymphocyte cytosolic 
protein 1), which allow the speculation that auto‑antibodies could contribute to chronic ASFV infections. Therefore, 
the use of proteomics could help understand ASFV pathogenesis and immune protection, opening new avenues for 
future research.
© The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
African swine fever virus (ASFV) is the causal agent of 
a haemorrhagic and often-lethal porcine disease, Afri-
can swine fever (ASF), which causes affected countries 
important economic losses. There is no vaccine avail-
able against the disease, albeit promising developments 
for future implementation are being currently devel-
oped [1]. ASF may range from an acute, highly lethal 
infection to subclinical chronic forms, depending on a 
complex contribution of viral and host factors [2]. The 
pig immune response to ASFV has been widely studied 
[3, 4], showing that the virus has effective mechanisms 
of evading pig defensive systems, thus contributing to 
the immune pathology observed during acute ASF, and 
to virus persistence in its hosts [5]. Studies about virus-
cells interaction have contributed significantly to unravel 
the mechanisms involved in pig response [3, 6–10]. In 
this regard, it has been shown that the ASFV genome 
encodes a large number of genes that have been identi-
fied as playing a role in host immune evasion including: 
interferon (IFN) inhibition by several multigene family 
members [11], the NF-κB and NFAT inhibitor A238L or 
the apoptosis inhibitor A179L, among others. All these 
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aspects have recently been reviewed [12]. In addition, it 
is known that ASFV controls host transcription and cel-
lular machinery of protein synthesis [13] thus contribut-
ing to pathology. The high complexity of ASFV, together 
with its tropism for the immune system of the host, com-
plicates the understanding of ASF pathogenesis. Both 
ASFV-specific antibodies [4] and  CD8+ T-cells [3, 14], 
have been postulated as key players in the protection 
against ASFV. The dual role of the immune system during 
ASFV infection becomes evident again during chronic 
ASF-infections, characterized by mild clinical signs 
associated, on occasions, with immunopathological pro-
cesses, such as immune complexes and swine IgM, IgG 
and C1q depositions [15]. Swine macrophages are the 
main target for ASFV, and depending on multiple factors, 
including the virulence of the ASFV strain, the immune 
system can play a dual role during both, ASFV-protection 
but also contributing to the virus pathogenesis. As men-
tioned above, virulent ASFV strains can evade the early 
recognition of the immune system, strategies that facili-
tate their replication and in  vivo dissemination that, in 
the last stages of acute infection, provoke tissue destruc-
tion, leukopenia and total dysregulation of the immune 
system, reflected with the typical storm of cytokines thus 
contributing to ASF acute pathogenesis [16]. Conversely, 
infections with attenuated ASFV strains normally render 
subclinical infections that are rapidly recognized by the 
innate immune system and cleared from the body, yield-
ing pigs capable of resisting homologous lethal challenge 
[16].
Here we extend these studies by presenting a com-
parative proteomic analysis using gastrohepatic lymph 
nodes (GLN) from pigs infected in  vivo with either the 
attenuated E75CV1 strain or with E75, its parental viru-
lent ASFV strain, at different days post-infection (dpi); 
a model system previously used to unmask some of the 
mechanisms involved in homologous protection against 
ASFV [16]. Since ASFV-infection modifies the expres-
sion patterns of host cell proteins, the application of 
proteomic approaches might help to clarify the intrin-
sic mechanism involved in ASFV-host interactions, as 
has been demonstrated [10, 17]. These methodologies 
have contributed to better understandings of how some 
viruses reprogram cell resources for their own benefit, 
or avoid host defensive mechanisms to survive in their 
host [18], but a limited number of proteomic studies 
have been carried out with swine pathogens. Thus, pro-
teomic strategies have been used to study the differences 
observed after in vitro infection of Vero cells with viru-
lent or attenuated strains of porcine epidemic diarrhoea 
virus [19], or PK-15 cells infected with classical swine 
fever virus [20]. Additionally, our group has previously 
described the protein profile of lymph nodes of piglets 
inoculated with Porcine circovirus type 2 (PCV2) [21]. 
Two proteomic studies have been published so far for 
ASFV infection: the first one focussed on proteins dif-
ferentially expressed after ASFV-macrophage infection, 
although they were not specifically identified [17] and the 
second one, using Vero cells infected with the 608VR13 
ASFV isolate, identifying proteins involved in apoptosis 
or in the transcription modulation [10].
In this work, we have conducted the first 2-DE prot-
eomic approach and bioinformatic data analysis using 
lymph node tissue from pigs infected with two homolo-
gous ASFV strains with distinct virulence: the tissue 
culture adapted E75CV1, an attenuated virus, and its 
parental virulent E75 virus. In order to reach a deeper 
understanding of pig-ASFV interactions and swine 
immune responses, samples were obtained at different 
times post-infection. This large- scale proteomic study 
should provide a complete view of the major and impor-
tant functions and pathways altered during the infection 
process, and hopefully, it could be used in the future to 
develop anti-ASFV strategies.
Materials and methods
Experimental design for the in vivo experiment
The in  vivo experiment has been previously described 
and the animals and samples used in this analysis are 
the same as those used in experiment 2 of our previous 
study [16]. Briefly, a group of 24 pigs was infected with 
104 HAU50 of E75CV1, a second group of 18 pigs was 
infected using the same dose and route of the virulent 
E75 and finally a third group of 12 pigs remained unin-
fected (control group). Pigs from the three groups were 
sacrificed at days 1, 3 and 7 pi (6 or 3 per group and day) 
and 6 pigs from the attenuated E75CV1 and 3 from the 
control group were also sacrificed at day 31 pi. Lymph 
node samples of all animals (54 pigs) were analysed by 
2-DE and mass spectrometry (see below).
Two‑dimensional gel electrophoresis (2‑DE) and image 
analysis
GLN were subjected to mechanical dissociation in sam-
ple buffer (7 M urea, 2 M thiourea, 4% w/v CHAPS, 1% 
w/v DTT, 0.8% ampholytes, 0.2 M PMSF) by scraping and 
gentle squeezing. Each supernatant was recovered and, 
after clean up precipitation, lymph node protein extracts 
for each condition (control, E75-infected or E75CV1-
infected) and day (1, 3, 7 and 31 dpi) were pooled and 
analyzed by 2-DE following previously published meth-
ods [22]. Briefly, protein extracts were diluted in rehy-
dration buffer (7 M urea, 2 M thiourea, 4% w/v CHAPS, 
20  mM DTT, 0.5% Triton X-100, 0.5% ampholytes) and 
immobilized pH gradient strips of 17 cm (5–8 linear pH 
gradient, Bio-Rad) were rehydrated with 300 μL (500 μg) 
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of each protein solution and focused in a PROTEAN IEF 
Cell (Bio-Rad) using the following parameters: (1) active 
rehydration at 50 V for 12 h; (2) at 250 V for 15 min with-
out pause after rehydratation; (3) rapid ramp until reach-
ing 10 000 V/h and (4) until 80 000 V/h with slow ramped 
voltage. Previously, protein profile was analyzed by 2-DE 
on 3–10 pH gradient strips, finding that the resolved 
spots were concentrated in the 5–8 pH range. Second 
dimension was performed on 12% SDS–polyacrylamide 
gels using PROTEAN PlusTM Dodeca (Bio-Rad). Four 
replicated for each of the conditions (virulent, attenuated 
or control) were analyzed simultaneously for each dpi.
Gels were stained with SYPRO Ruby protein gel stain 
(Bio-Rad). Gel images were digitized with the FX Pro Plus 
Multi imager system (Bio-Rad) and analyzed with the PD 
Quest version 7.3 software (Bio-Rad). Spots detected 
by the program were matched between each gel in each 
group. Normalized protein spot volume (area multiplied 
by stain intensity) was calculated for each spot in the 
control sample and compared to its counterpart (sample 
from ASFV-infected animals). Intensity data were used 
to calculate differences in protein expression between 
groups (controls vs. E75 or E75CV1 infected samples), 
for each dpi, using a Student’s t test (p < 0.05) (two-tailed 
with unequal variances) after checking normality by the 
Wilks–Shapiro test. Differentially expressed spots were 
selected for protein identification by mass spectrometry.
Protein identification by mass spectrometry
Spots were automatically excised in a ProPic station 
(Genomic Solutions) and digested with modified por-
cine trypsin (sequencing grade; Promega), by using a 
ProGest digestion station (Genomic Solutions), as pre-
viously described [22]. Briefly, gel pieces were destained 
with ammonium bicarbonate/acetonitrile (ACN), and 
subsequently subjected to dehydration/rehydration 
cycles and dried. Gel pieces were digested with trypsin, 
peptides extracted with trichloroacetic acid and desalted 
and concentrated by using μC-18 ZipTip columns (Milli-
pore) in a ProMS station (Genomic Solutions). After that 
were loaded onto a 4800 MALDI-TOF/TOF Analyzer 
(Applied Biosystems) in automatic mode with the follow-
ing setting: for the Mass Spectrometry (MS) data, m/z 
range 800–4000 with an accelerating voltage of 20  kV, 
peak density of maximum 50 peaks per 200 Da, minimal 
S/N ratio of 10 and maximum peak at 65. Spectra were 
internally calibrated with peptides from trypsin autolysis 
(M + H+= 842.509, M + H+= 2211.104). For the MS/MS 
data, fragment selection criteria were a minimum signal/
noise (S/N) ratio of 5, a maximum number of peaks set 
at 65 and peak density of maximum 50 peaks per 200 Da. 
For each precursor selected for MS/MS analysis, frag-
ment mass values in the range from 60 to 10  Da below 
precursor mass were used to peptide identification. Pro-
tein identification was assigned by peptide mass finger-
printing and confirmed by MS/MS analysis of at least 
three peptides in each sample. Mascot 1.9 search engine 
(Matrixscience) was used for protein identification run-
ning on GPS software (Applied Biosystems) against the 
NCBI mammalian database (updated monthly). Only 
those proteins with a significant protein score (p < 0.05) 
according to Mascot were taken into account in subse-
quent analysis.
Functional analysis of the proteins
Differentially regulated proteins were analyzed through 
the use of Ingenuity Pathway Analysis software (IPA, 
 Ingenuity® Systems). This system identifies the func-
tions and canonical pathways that are most significant to 
the data set, supported by canonical information stored 
in the Ingenuity Knowledge Base. Fisher’s exact test was 
used to calculate a p value determining the probability 
that the association between the proteins in the dataset 
and the functions and canonical pathways is explained by 
chance alone. These p-values are calculated based on the 
number of proteins that participate in a given function 
or pathway relative to the total number of occurrences 
of proteins in functions or pathway annotations stored in 
the Ingenuity Pathways Knowledge Base [21]. The whole 
Ingenuity Knowledge Base was considered as reference 
set.
Results
Two‑dimensional electrophoresis reveals differential 
protein expression kinetics after in vivoinfection 
with either virulent E75 or attenuated E75CV1 
ASFV‑isolates
To widen and deepen our understanding of the mecha-
nisms underlying ASFV-pathogenesis and immune 
response to ASFV, we characterized the variation in GLN 
protein profiles of pigs infected with E75 (high virulence) 
and E75CV (low virulence) at different times post-infec-
tion using a 2-DE proteomics approach. Our previous 
study [16] allowed to verify homogeneity between ani-
mals and that no outlier there was among the pigs stud-
ied. In these conditions, the technical variation can be 
the dominate source of variation [23]. To overcome the 
inherent experimental variations of this technique, we 
performed simultaneously four replicate (four gels) 
of each day and condition and more than 85% of the 
spots were common between gels. After image analysis 
and visual confirmation of gels, around 800 spots were 
detected. Paired analyses between infected and control 
groups detected 80, 94, 62 and 39 differently changed 
spots with E75CV1 attenuated strain at 1, 3, 7 and 31 dpi 
respectively, corresponding to 42, 72, 53 and 33 different 
Page 4 of 15Herrera‑Uribe et al. Vet Res  (2018) 49:90 
proteins. With E75 virulent isolate 57, 83 and 34 spots 
result differentially expressed at 1, 3  years, 7  dpi, cor-
responding to 33, 60 and 24 different proteins. In some 
cases, multiple spots were unambiguously identified as 
the same protein, it could arrive due to post-translational 
modification (crucial in the control of numerous regu-
latory pathways, degradation of proteins, biochemical 
alterations or pathogenesis), different isoforms derived 
from different genes of a multigen family, proteolytic 
damage or chemical modification of protein during sam-
ple preparation.
Differences in protein profiles were not only observed 
between virulent and attenuated ASFV strains, but also 
were shown between the different times post-infection 
tested. The most dramatic changes found affected lymph 
nodes from pigs infected with E75 at day 7pi, coincid-
ing with the late phase of the E75 lethal virus infection, 
probably reflects the massive tissue destruction observed 
at this time post-infection, with only a few intact cells 
being present, mostly corresponding to infiltrates of 
ASFV-infected macrophages [16]. GLNs from day 7 E75-
infected pigs showed most proteins downregulated while 
infection with the attenuated E75CV1 virus upregulates 
a larger number of proteins than the virulent E75 strain 
at days 1, 3 and 7 pi, respectively (Table 1). As expected, 
there are a considerable number of spots in common that 
change after infection with the two isolates (36, 62 and 
23 at 1, 3 and 7 dpi respectively), while the rest became 
altered only during the infection with one of the isolates 
(Additional files 1, 2, 3, 4 show the changes of expres-
sion of all proteins altered after infection and additional 
MS/MS information is available in Ref. [24]). The pro-
teins with the largest change in fold change are shown 
in Tables 2, 3, 4, 5. Similarly, the expression of some pro-
teins became apparent at specific times post-infection, 
while others were affected throughout the infection. As 
good examples, albumin and cytoskeletal proteins such 
as actin-like proteins were commonly affected by both 
ASFV strains, while many other proteins were differen-
tially affected, such as heat shock protein B1 (HSPB1), 
involved in stabilizing actin filaments after stress, that 
results up-regulated exclusively at 1 dpi with E75CV1 
[25]. Of special interest were the proteins differentially 
regulated after the infection with the E75CV1 attenuated 
strain, reflecting changes in the immune system. Inter-
estingly, some of these proteins became upregulated as 
soon as day 1 pi with E75CV1 (Additional file 1), includ-
ing proteasome activator complex (PSME 1 and 2). Two 
proteins were inversely regulated after infection with the 
attenuated E75CV1 strain: HSPA1B and vimentin. While 
HPSA1B showed a downregulation, vimentin was upreg-
ulated at day 1 pi. Other proteins specifically upregulated 
at day 1 pi with E75CV1 were HSPB1, enolase or lym-
phocyte cytosolic protein 1 (LCP-1) (Additional file  1). 
As expected, the early events described at day 1 pi with 
E75CV1, correlate with the profile of upregulated pro-
teins specifically found by day 31 pi and related with the 
immune response (Additional file 4), including immuno-
globulin component fractions, such as IGKC and IGHG3, 
or components of the proteasome such as PMSA1 and 
PMSA6. The up-regulation of retinol-binding protein 4 
(responsible for retinol transport), galactose mutarotase 
or calreticulin are also of interest.
Functional analysis of differentially expressed 
proteins after in vivo infection with either virulent E75 
or attenuated E75CV1 ASFV‑isolates
Bioinformatic tools were employed to biologically inter-
pret the data set of protein obtained from 2-DE analy-
sis, with the aim of gaining an insight into biological 
functions and pathways associated with the proteome 
response of porcine GLN to ASFV, as well as to dis-
cover differences in processes that occur after infection 
with each one of the ASFV-strains. Therefore, we have 
analyzed our data set using IPA, focused on cell func-
tions and on canonical pathways, so-called because 
they contain well-established knowledge about specific 
relationships between groups of proteins. Differentially 
expressed proteins were involved in different aspects of 
the host–pathogen interaction (Additional files 5, 6, 7, 8, 
9, 10, 11). With respect to functions, inflammatory and 
immunological disease were functions altered by both 
virus, but a greater number of proteins involved in these 
functions were differentially expressed after E75CV1 
than E75 infection, at 1 dpi. Thus, we have found the up-
regulation of proteins such as: HSPA5 and HSPB1, LCP1, 
vimentin, C reactive protein or hemopexin, a protein 
that positively regulates the interferon-gamma-mediated 
signaling pathway [26]. Accordingly, our previous qPCR 
results [16] showed an over-expression of interferon-
gamma after infection with E75CV1 but not due to E75 
infection, at 1 dpi. Conversely, GLNs from E75-infected 
Table 1 Number of regulated spots in porcine lymph node at different times post-infection 
1 dpi 3 dpi 7 dpi 31 dpi
E75CV1/control (attenuated) 51 ↑ 29 ↓ 49 ↑ 45 ↓ 28 ↑ 34 ↓ 35 ↑ 4 ↓
E75/control (virulent) 32 ↑ 25 ↓ 30 ↑ 53 ↓ 1 ↑ 33 ↓ – –
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Table 2 The top proteins with the largest change in expression in response to ASFV infection (1 dpi) 
Attenuated‑control
ID SSP ID Gen name Protein name pI Mw (kDa) % coverage Fold change p value
5605 F1RUN2 ALB Serum albumin Sus scrofa 5.98 71.60 19 34.7 0.0006
605 P02543 VIM Vimentin Sus scrofa 5.06 53.70 63 27.5 0.001
1307 Q6QAQ1 ACTB Actin.cytoplasmic 1 Sus scrofa 5.29 42.1 19 11 0.0002
6718 P02554 TUBB Tubulin beta chain Sus scrofa 4.78 50.30 17 10.1 0.0024
8411 I7GKE9 EEF2 Similar to human eukaryotic translation elongation factor 
Macaca fascicularis
5.93 36.4 21 6.7 0.002
4807 F1RMN7 HPX Hemopexin Sus scrofa 6.59 52.10 21 4.5 0.0003
8315 F1RS36 HSPA5 78 kDaglucose‑regulated protein Sus scrofa 5.21 70.3 24 4.2 0.0175
8219 I3L816 HNRNPH1 Heterogeneous nuclear ribonucleoprotein H Sus scrofa 6.44 46.6 34 3.8 0.0014
8107 K7EJP1 ATP5A1 ATP synthase subunit alpha.mitochondrial Homo sapiens 5.51 15.40 29 3.5 0.0047
9602 I3LK59 ENO Enolase Sus scrofa 8.93 38.20 29 3.4 0.0005
4806 Q6S4N2 HSPA1B Heat shock 70 kDa protein 1B Sus scrofa 5.6 70.30 18 − 23.1 0
9508 I3LEC2 PCBP1 Poly(rC)‑binding protein 1 Sus scrofa 6.66 37.9 39 − 15 0.0001
7420 F1RKU0 IDH3A Isocitrate dehydrogenase [NAD] subuni talpha, mitochon‑
drial Sus scrofa
6.72 40.1 24 − 10 0.0105
407 F1M0S3 TPM2 Tropomyosin beta chain Rattus norvegicus 5.19 31.1 38 − 9.6 0.0003
502 C9J9K3 RPSA 40S ribosomal protein SA Homo sapiens 5.15 30 62 − 8.6 0.0001
302 P62258 YWHAE 14‑3‑3 protein epsilon Homo sapiens 4.79 29.2 44 − 7.5 0.0023
9804 P09571 TF Serotransferrin Sus scrofa 6.93 78.90 36 − 6.9 0.0013
9401 P00355 GAPDH Glyceraldehyde‑3‑phosphate dehydrogenase Sus scrofa 8.51 36.1 34 − 5.7 0.001
205 F2Z558 YWHAZ 14‑3‑3 protein zeta Sus scrofa 4.77 28.20 42 − 5.4 0.0032
9107 F1S3U9 PRDX1 Peroxiredoxin 1 Sus scrofa 8.67 22.1 44 − 5.1 0.0052
Virulent‑control
ID SSP ID Gen name Protein name pI Mw (kDa) % coverage Fold change p value
4107 F1RUN2 ALB Serum albumin Sus scrofa 5.98 71.60 5 13.4 0.0012
6718 P02554 TUBB Tubulin beta chain Susscrofa 4.78 50.30 17 11.3 0.0003
5411 F1RPH0 PGK1 Phosphoglycerate kinase Sus scrofa 6.32 43.4 30 7.3 0.0009
8214 D0G7F6 TPI1 Triosephosphate isomerase Sus scrofa 6.54 23.90 89 6.5 0.001
8411 I7GKE9 EEF2 Similar to human eukaryotic translation elongation factor 
Macaca fascicularis
5.93 36.4 21 6.5 0.0023
4308 B6VNT8 ACTC1 Alpha actin 1 Sus scrofa 5.23 42.3 8 5 0.0005
8107 K7EJP1 ATP5A1 ATP synthase subunit alpha.mitochondrial Homo sapiens 5.51 15.40 29 3.5 0.0002
8219 I3L816 HNRNPH1 Heterogeneous nuclear ribonucleoprotein H Sus scrofa 6.44 46.6 34 3.4 0.0008
1410 Q9N0Y9| TMOD3 Ubiquitous tropomodulin U‑Tmod Sus scrofa 4.98 39.7 31 2.4 0.0002
7504 F1SVB0 CAPG Macrophage‑capping protein Sus scrofa 5.88 39.2 23 2.3 0.0022
9107 F1S3U9 PRDX1 Peroxiredoxin 1 Sus scrofa 8.67 22.1 44 − 6.1 0.0009
302 P62258 YWHAE 14‑3‑3 protein epsilon Homo sapiens 4.79 29.2 44 − 13.6 0.0027
8806 P09571 TF Serotransferrin Sus scrofa 6.93 78.9 32 − 11.7 0.0001
301 Q5ISS9 YWHAQ 14‑3‑3 protein theta isoform Sus scrofa 4.7 29.20 49 − 11.4 0.0002
7715 F1RFN9 FSCN1 Fascin Sus scrofa 6.04 55.20 26 − 9.8 0.001
8404 A2A6G8 Lasp1 LIM and SH3 domain protein 1 Mus musculus 9.14 12.1 50 − 7.5 0.0004
8510 I3LDC7| IDH1 Isocitrate dehydrogenase [NADP] (Fragment) Sus scrofa 7.64 48.7 24 − 7 0.0011
407 F1M0S3 TPM2 Tropomyosin beta chain Rattus norvegicus 5.19 31.1 38 − 5.2 0.0007
502 C9J9K3 RPSA 40S ribosomal protein SA Homo sapiens 5.15 30 62 − 4.8 0.0002
5113 Q08024 CBFB Core‑binding factor subunit beta Mus musculus 5.59 22.2 31 − 4.4 0.0008
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Table 3 The top proteins with the largest change in expression in response to ASFV infection (3 dpi) 
Attenuated‑control
ID SSP ID Gen name Protein name pI Mw (kDa) % coverage Fold change p value
7226 O15144 ARPC2 Actin‑related protein 2/3 complex subunit 2 Homo sapiens 6.84 34.4 45 13.1 0.0017
5435 P50395 GDI2 Rab GDP dissociation inhibitor beta Sus scrofa 6.31 50.70 49 12.4 0.0077
1427 Q0QEN7 ATP5B ATP synthase subunit beta Sus scrofa 4.99 47 58 10.7 0.0121
1133 P20700 LMNB1 Lamin‑B1 Homo sapiens 5.11 66.40 14 8.5 0.0103
3625 P11142 HSP7C Heat shock cognate 71 kDa protein Homo sapiens 5.37 70.80 27 8.4 0.0052
8533 Q6MZU6 IGHM IgG heavy chain Sus scrofa 6.82 52.90 25 6.1 0.0247
8321 B1ALA9 PRPS1 Phosphoribosyl pyrophosphate synthetase 1 Rattus 
norvegicus
7.62 24.40 37 5.6 0.0003
2322 P04899 GNA12 Guanine nucleotide‑binding protein G(i) subunit alpha‑2 
Sus scrofa
5.35 41.00 52 5.4 0.0122
2548 P54920 NAPA Alpha‑soluble NSF attachment protein Homo sapiens 5.23 33.66 65 5.2 0.0021
6128 Q8MJ14 GPX1 Glutathione peroxidase 1 Sus scrofa 6.73 22.40 22 5.1 0.0013
2026 O89052 TUBA1B Alpha‑tubulin Mus musculus 4.85 11 60 − 34.8 0.0008
1021 P08835 ALB Serum albumin Sus scrofa 6.08 69.70 18 − 24.3 0.0000
2131 P84856 ACTB Actin.cytoplasmic 1 Cercopithecus pygerythrus 5.55 40.4 21 − 18.1 0.0104
4017 P61981 YWHAG 14‑3‑3 protein gamma Homo sapiens 4.8 28.30 47 − 17.3 0.0210
3017 P63104 YWHAZ 14‑3‑3 protein zeta/delta Homo sapiens 4.73 27.90 46 − 16.5 0.0001
4135 P00829 ATPB ATP synthase subunit beta.mitochondrial Bos taurus 5.15 56.2 29 − 11.2 0.0043
4013 P31946 YWHAB 14‑3‑3 protein beta/alpha Homo sapiens 4.76 28.20 63 − 8.9 0.0000
4234 Q9MYP6 HSD17B14 17‑beta‑hydroxysteroid dehydrogenase 14 Bos taurus 6.19 28.40 7 − 5.9 0.0070
8148 P09571 TF Serotransferrin Sus scrofa 6.93 76.90 3 − 4.9 0.0015
1018 Q2HJ57 COTL1 Coactosin‑like protein Bos taurus 5.1 16.00 36 − 4.6 0.0199
Virulent‑control
ID SSP ID Gen name Protein name pI Mw (kDa) % coverage Fold change p value
5435 P50395 GDI2 Rab GDP dissociation inhibitor beta Sus scrofa 6.31 50.70 49 16.3 0.0108
5142 P19133 FTL Ferritin light chain Sus scrofa 5.8 28.70 32 11.6 0.0001
7226 O15144 ARPC2 Actin‑related protein 2/3 complex subunit 2 Homo sapiens 6.84 34.4 45 8.7 0.0036
1427 Q0QEN7 ATP5B ATP synthase subunit beta Sus scrofa 4.99 47 58 8.6 0.0000
1133 P20700 LMNB1 Lamin‑B1 Homo sapiens 5.11 66.40 14 6.3 0.0004
7137 P60900 PSMA6 Proteasome subunit alpha type‑6 Homo sapiens 6.34 27.30 26 5.1 0.0004
1640 P01009 SERPINA1 Alpha‑1‑antitrypsin Sus scrofa 5.54 47.4 11 4.2 0.0029
6332 P56471 IDH3A Isocitratedehydrogenase [NAD] subunitalpha Sus scrofa 6.72 40.10 50 4.0 0.0003
1130 P52552 PRDX2 Peroxiredoxin‑2 Sus scrofa 4.66 14.10 36 3.6 0.0000
1224 P08758 ANXA5 Annexin A5 Homo sapiens 4.94 35.8 59 3.2 0.0034
3123 P84856 ACTB Actin.cytoplasmic 1 Cercopithecus pygerythrus 5.55 40.4 29 − 35.6 0.0082
4017 P61981 YWHAG 14‑3‑3 protein gamma Homo sapiens 4.8 28.30 47 − 19.8 0.0190
1021 P08835 ALB Serumalbumin Sus scrofa 6.08 69.70 18 − 12.7 0.0000
2026 O89052 TUBA1B Alpha‑tubulin Mus musculus 4.85 11 60 − 11.9 0.0001
4013 P31946 YWHAB 14‑3‑3 protein beta/alpha Homo sapiens 4.76 28.20 63 − 11.1 0.0000
1331 Q9N0Y9 TMOD3 Tropomodulin 3 Sus scrofa 4.98 39.70 21 − 10.5 0.0051
4234 Q9MYP6 HSD17B14 17‑beta‑hydroxysteroid dehydrogenase 14 Bos taurus 6.19 28.40 7 − 9.8 0.0062
3017 P63104 YWHAZ 14‑3‑3 protein zeta/delta Homo sapiens 4.73 27.90 46 − 7.3 0.0000
515 P13489 RNH1 Ribonuclease inhibitor Sus scrofa 4.76 50.70 64 − 5.7 0.0162
1018 Q2HJ57 COTL1 Coactosin‑like protein Bos taurus 5.1 16.00 36 − 4.6 0.0160
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Table 4 The top proteins with the largest change in expression in response to ASFV infection (7 dpi) 
Attenuated‑control
ID SSP ID Gen name Protein name pI Mw (kDa) % coverage Fold change p value
1509 Q0QEM6 ATP5B ATP synthase subunit beta Sus scrofa 4.99 47.10 72 26.6 0.0236
1405 F8VYX6 TUBB Tubulin beta chain Homo sapiens 5.1 48.90 37 9.1 0.0222
8512 F1RFI1 TUFM Elongation factor Tu Sus scrofa 6.72 49.70 46 6 0.0004
8606 P01790 IGH Ig heavy chain V region Mus musculus 8.01 13.70 24 5.7 0.0232
1612 P02543 VIM Vimentin Sus scrofa 5.06 53.70 57 4.5 0.0097
3319 B4DWA6 CAPZB Highly similar to F‑actin capping protein subunit beta 
Homo sapiens
5.77 37.8 31 4.1 0
4005 Q2TBX5 SSR4 Translocon‑associated protein subunit delta Bos taurus 5.49 19.00 37 3.9 0.095
7412 Q9GKX6 GALM Aldose 1‑epimerase Sus scrofa 6.31 38.00 30 3.7 0.0044
8209 B5APU7 ARPC2 Actin‑related protein 2/3 complex subunit 2 Sus scrofa 6.84 34.3 63 3.7 0.025
7108 D6RBM0 HNRNPH1 Heterogeneous nuclear ribonucleoprotein H Homo 
sapiens
6.97 24.2 62 3.7 0.0033
3005 B3KWQ3 ACTG Highly similar to Actin. cytoplasmic 2 Homo sapiens 5.2 28.50 29 − 12 0.0055
7309 F1RUN2 ALB Serum albumin Sus scrofa 5.98 71.60 30 − 5 0.0004
3720 Q5T6W5 HNRNPK Heterogeneous nuclear ribonucleoprotein K Homo 
sapiens
5.46 47.70 41 − 4.9 0.018
1308 A5D989 EEF1D Elongation factor 1‑delta Bos taurus 4.94 31.2 27 − 4.8 0
3723 F1MUZ9 HSPD1 60 kDa chaperonin Bos taurus 5.71 61.10 42 − 4.3 0.0017
3318 P11493| PPP2CB Serine/threonine‑protein phosphatase 2A catalytic subu‑
nit beta isoform Homo sapiens
5.46 34.1 35 − 3.2 0.023
4112 Q1W2K3 PSMB10 Proteasome subunit beta Sus scrofa 6.09 29.20 23 − 3.2 0.0004
2613 F1RG16 HNRNPF Heterogeneous nuclear ribonucleoprotein F Sus scrofa 5.32 45.90 42 − 3.1 0.0452
305 I3L813 PCNA Proliferating cell nuclear antigen Sus scrofa 4.57 29.1 63 − 2.9 0.005
2309 G7P8A3 EGM_15385 Serine/threonine‑protein phosphatase Macaca fascicularis 5.55 33.9 46 − 2.4 0.0003
Virulent‑control
ID SSP ID Gen name Protein name pI Mw (Kda) % coverage Fold change p value
3516 F1MRD0 ACTB Actin.cytoplasmic 1.Bos taurus 5.16 42.20 38 6.1 0.0255
7309 F1RUN2 ALB Serumalbumin Sus scrofa 5.98 71.60 30 − 26 0.011
3005 B3KWQ3 ACTG Highly similar to Actin. cytoplasmic 2 Homo sapiens 5.2 28.50 29 − 24 0.0214
6417 Q8IY98 ACTR2 Actin‑related protein 2 Homo sapiens 5.77 39.90 43 − 6.4 0.0004
6313 O88550 CASP7 Caspase 7 Rattus norvegicus 5.53 34.9 17 − 5.5 0.0125
2012 Q0IIA3 SRI Sorcin Bos taurus 5.11 20.60 20 − 4.7 0.014
9012 Q9BGI4 PRDX1 Peroxiredoxin 1 Bos taurus 8.81 22.4 40 − 4.6 0.0013
3314 Q15181 PPA1 Inorganic pyrophosphatase Homo sapiens 5.54 33.1 41 − 4.4 0.0374
2613 F1RG16 HNRNPF Heterogeneous nuclear ribonucleoprotein F Sus scrofa 5.32 45.90 42 − 4.3 0.0357
207 P61981 YWHAG 14‑3‑3 protein gamma Homo sapiens 4.8 28.4 59 − 3.4 0.017
2309 G7P8A3 EGM_15385 Serine/threonine‑protein phosphatase Macaca fascicularis 5.55 33.9 46 − 2.8 0.0223
6416 Q99LC3 NDUFA10 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex 
subunit 10. Mus musculus
7.63 40.80 22 − 2.3 0.027
2208 F2Z5C1 ANXA5 Annexin Sus scrofa 4.95 33.2 59 − 2.1 0.0313
305 I3L813 PCNA Proliferating cell nuclear antigen Sus scrofa 4.57 29.1 63 − 2 0.0401
2108 F1SQW8 ARHGDIB Rho protein dissociation inhibitor homolog Sus scrofa 5.08 22.90 55 − 1.8 0.047
306 F1M0S3 TPM2 Tropomyosin beta chain Rattus norvegicus 5.19 31.1 40 − 1.8 0.0155
7213 K7D9V9 HNRNPH3 Heteroproteinous nuclear ribonucleoprotein H3 Pan 
troglodytes
6.36 35.2 68 − 1.7 0.0419
Page 8 of 15Herrera‑Uribe et al. Vet Res  (2018) 49:90 
pigs showed, at day 1 pi, the specific downregulation of 
SERPINA3, an acute phase protein that is induced during 
inflammation [27] or vitamin D-binding protein (impli-
cated in macrophage activation and inflammation) [28], 
most probably contributing to a delayed inflammatory 
response to the virulent isolate.
Figure  1 also included other functions (derived from 
the Ingenuity Pathways Analysis) significantly altered at 
early times after infection with both virus strains, e.g. 
those associated to free radical scavenging, cell death 
and cell-to-cell signaling and interaction, while cellular 
assembly and organization or cellular functions showed 
fewer modifications. Nevertheless, by day 7 pi with 
E75CV1, coinciding with the recovery of the infected 
pigs [16], these latter functions became more relevant. 
Conversely, GLN from E75-infected pigs by day 7 pi, 
showed protein profiles enriched in functions related 
to tissue destruction when compared to E75CV1; these 
were mainly associated with connective tissue disorders, 
skeletal and muscular disorders or with organismal injury 
and abnormalities. Some of these abnormalities became 
evident as early as at day 3 pi, coinciding with the ASFV 
replication in the GLN [16].
The association of the proteins significantly affected 
by ASFV infection with canonical pathways is shown in 
Table 6. As expected, the remodelling of epithelial adher-
ent junction pathways was enriched for both viruses. 
In this canonical pathway, several members of the actin 
family participate, shown in here as differentially regu-
lated. Also, clathrin-mediated endocytosis signaling 
pathways, involving molecules such as actin, heat shock 
proteins, serpin or transferrin, were regulated at all 
times post-infection with the exception of day 1 pi with 
E75CV1. One of the most remarkable and novel observa-
tions of our work affects the 14-3-3 mediated signaling, 
inhibited by both isolates at 1 and 3 dpi. It is also worth 
highlighting the differential regulation of Rho GTPases in 
GLNs from E75CV1 infected pigs between days 1 and 7, 
coinciding with the induction of innate immunity and the 
resolution of the subclinical ASFV infection [29]. Regard-
ing pathways regulated by only one virus, or in some 
cases at only times post-infection, is worthy to mention 
the G2/M DNA damage checkpoint regulation, involving 
the different 14.3.3 isoforms which we have been found 
downregulated after infection.
Table 5 The top proteins with the largest change in expression in response to E75CV1 infection (31 dpi) 
Attenuated‑control
ID SSP ID Gen name Protein name pI Mw (Kda) % coverage Fold change p value
4611 Q4V7C7 ACTR3 Actin‑related protein 3 homolog Rattus norvegicus 5.61 47.6 32 10.1 0.0001
7219 Q45FY6 HPRT1 Hypoxanthine–guanine phosphoribosyl transferase 
Sus scrofa
6.3 24.80 61 6 0.0383
1903 A0A024R972 LAMC1 Laminin. gamma 1.isoform CRA_a Homo sapiens 4.94 17.90 11 5.8 0.0189
7518 P08835 ALB Albumin Sus scrofa 5.92 71.40 37 4.8 0.024
5513 P00348 HADH Hydroxyacyl‑coenzyme A dehydrogenase Sus scrofa 9.02 34.20 32 3.8 0.0255
3211 Q06AS6 GNAI2 Guanine nucleotide binding protein. alpha inhibiting 
activity polypeptide 2 Sus scrofa
5.35 41 64 3.2 0.0035
8412 P60901 PSMA6 Proteasome subunit alpha type‑6 Rattus norvegicus 6.34 27.80 51 2.5 0.0193
3410 A0PA01 SERPINB9 Serpin peptidase inhibitor.clade B (ovalbumin).member 
9 Sus scrofa
5.37 42.8 61 2.4 0.0137
7212 P04431 IGKC Immunoglobulin kappa light chain Sus scrofa 8.65 12.20 39 2.4 0.0081
2514 P60953 CDC42 Chain B. Structure Of The Complex Between Dock9 and 
Cdc42. Homo sapiens
6.3 21.50 45 2.3 0.0019
7220 P31943 HNRNPH Heterogeneous nuclear ribonucleoprotein H Homo 
sapiens
5.89 49.50 36 2.2 0.027
6112 P01860 IGHG3 Ig gamma 3 chain constant region. Sus scrofa 7.25 36.50 28 2.2 0.0055
5119 P80031 GSTP1 Glutathione S‑transferase P1 Sus scrofa 8.07 23.7 46 2.1 0.0089
7214 Q9GKX6 GALM Galactose mutarotase Sus scrofa 6.31 38.00 44 1.9 0.019
7614 P52193 CALR Calreticulin Bos taurus 4.31 46.50 46 1.8 0.0334
7514 P01834 IGKC Ig kappa light chain Sus scrofa 8.65 12.10 41 1.8 0.0061
5118 P27485 RBP4 Retinol‑binding protein 4 Sus scrofa 5.41 23.4 19 1.8 0.0205
1711 P08670 VIM Vimentin Homo sapiens 5.03 53.7 58 − 3.3 0.0109
8213 B8XSK0 CPNE1 Copine 1 Sus scrofa 5.43 59.6 26 − 2.6 0.0094
1611 Q5S1U1 HSPB1 Heat shock protein beta‑1 Sus scrofa 6.23 22.90 16 − 2.3 0.0064
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Discussion
Proteome approaches are being increasingly used in 
many different systems to investigate host–microbe 
interactions and it has provided important information 
about the protein profile of cells infected with ASFV [10, 
17]. The results presented here could complement the 
aforementioned ones since they have been performed 
with infected pig tissue. In this context, in  vivo models 
could help to reflect the multiple events undergone by the 
host upon pathogen infection. Here, we applied a prot-
eomics approach, based on 2-DE coupled to an in  vivo 
experiment, to obtain new insights about the differential 
responses triggered by attenuated and virulent homolo-
gous ASFV strains. Lymphnodes are complex tissues 
composed by different cell types and, despite ASFV main 
targets are the macrophages, it is known that the effect 
of virus infection is not only restricted to the infected 
cell but also to the cascade of events it provokes the 
massive apoptosis induced in surrounding non-infected 
lymphocytes, this being a key event for ASF pathogen-
esis, responsible for lymphoid organ impairment in acute 
ASFV infection [30]. Besides, the lesions found in ours 
previous manuscript [16] after necropsy together with a 
comparative transcription profile of key immune media-
tors that were differentially modulated throughout the 
infections point gastrohepatic lymph node as the organ 
of choice to improve our knowledge about of the differ-
ential porcine response against virulent or attenuated 
ASFV isolated, to further compare globally the immu-
nopathogenesis of both virus strains.
Also, we used IPA in a hypothesis generative man-
ner aiming to unmask the most relevant functions and 
pathways altered throughout the infection in GLN, one 
of its main target organs. Overall, the analysis shows 
that, together with pathways involved in host-immune 
responses, a significant number of other host functions 
are modified, demonstrating the complex host-virus 
interactions that occur in  vivo. Despite the much lower 
ASFV load observed after infection with the attenuated 
ASFV strain [16], major protein changes were detected 
early after infection with E75CV1, affecting not only the 
infected macrophages, but also surrounding cell-types in 
an indirect manner. Therefore, E75 and E75CV1 not only 
differed in the kinetics and in the clinical symptoms they 
provoke, but also in the pathways activated throughout 
the infections. The fewer number of proteins with viru-
lent isolated at 1 dpi might help explain the failure of the 
innate immune system to detect and control the first 
rounds of E75-replication, thus allowing its rapid spread. 
Conversely, efficient regulation of the innate immune sys-
tem became evident for E75CV1 as early as at 1 day pi. 
As example, the implication of the Rho GTPases signal-
ling pathway by E75CV1 throughout infection, (Table 6), 
perhaps confirming the relevance of this pathway in the 
innate immune system. Although the best-known func-
tion of this protein family is regulate and coordinates of 
Figure 1 Enriched functions associated with the response of porcine lymph node to ASFV during infection. The analysis is derived from the 
Ingenuity Pathways Analysis.
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actin and microtubule cytoskeletal dynamics and adhe-
sion [31], Rho GTPases regulate numerous basic cell 
functions including regulation of the signaling pathways 
and cellular responses that enable to phagocytes per-
form their innate immune functions to respond invading 
pathogens. Thus, they are key regulators of cell migra-
tion (through various cell-surface receptors as TLRs), 
reactive oxygen species (ROS) production by NADPH 
oxidase, phagocytosis and degranulations well as a essen-
tial, and perhaps unique, roles in the motile responses of 
leukocytes [32]. Another studies also indicate that Rho 
GTPases provide alternative pathways to regulate NF-kB 
transcriptional activity in cells of the innate immune sys-
tem [32].
Several other proteins became differentially regulated 
by day 1 pi, as vimentin, enolase, HSPB1 or lympho-
cyte cytosolic protein 1 (LCP-1) (Additional file 1) from 
E75CV1-pigs. Vimentin has been described as an impor-
tant molecule during ASFV morphogenesis by changing 
its localization to viral factories after in  vitro infection 
[33]. Thus, the upregulation of vimentin, at day 1 pi, 
might be an indirect effect provoked by E75CV1 infec-
tion on surrounding non-infected cells. Coincidently, 
vimentin and other proteins specifically upregulated at 
day 1 pi with E75CV1, such as HSPB1, enolase or LCP-1 
(Additional file  1), share both their potential role in 
immune defense and their description as autoantigens 
in autoimmune disorders [34]. In particular, the role of 
HSPs as immunogenic molecules able to activate T cells 
has been long known [35] and several reports have shown 
that pretreatment with HSPs protects from autoimmune 
disease [36]. Also, T-cell response to α-enolase could be 
involved in the pathogenesis of autoimmune diseases 
[37]. We are currently trying to unmask the potential 
presence of auto-antibodies in pigs infected with E75CV1 
by using sera from day 31 pi and the upregulated autoan-
tigens found at day 1 pi. These markers might be of utility 
to diagnose chronic infections and/or to better under-
stand ASFV pathogenesis during chronic infections.
Of particular interest could be the complex regulation 
found for several members of the heterogeneous nuclear 
ribonucleoprotein (hnRNP) complex, RNA-binding pro-
teins involved in downstream gene regulation and G2/M 
DNA damage checkpoint regulation, apoptosis and 
immune regulation [38]. hnRNPH1, a protein previously 
shown as being involved in virus replication [39], was 
upregulated at day 1 pi with both viruses, overexpression 
that was maintained for the attenuated E75CV1 virus at 
day 3 and 7 pi. It has been reported that upregulation 
of hnRNPH causes a decrease in HIV virion production 
[40]. Interestingly, it is worth noting the involvement 
of hnRNPH expression with TNF-α production [41] 
and NF-κB activation, both proteins being involved in 
inflammation and immune response. In Hepatitis C virus 
infection, it has been proposed that hnRNP might limit 
the amount of viral RNA genomes available for incorpo-
ration into virus [42]. These changes in expression could 
be significant and add information to the only described 
interaction between the ASFV p30 antigen and hnRNPK 
in Vero infected cells [43]. The authors suggest that the 
interaction hnRNPK-p30 could contribute to the host 
cell shut-off and represent a possible additional mecha-
nism by which ASFV down-regulates host cell mRNA 
translation.
Together with pathways involved in immune responses, 
it is worth highlighting, the pathways involved in cytoskel-
etal and epithelial adherent junction remodeling (Table 6), 
reflecting the use that ASFV makes of cytoskeleton from 
virus entry to virus morphogenesis and cell egress [9, 44]. 
This result perfectly correlates with the function that this 
pathway plays during ASFV entry in pig cells [45], involv-
ing molecules such as actin, heat shock proteins, serpin or 
transferrin, which have been found altered in our study. 
Similarly, the clathrin-mediated endocytosis pathways 
here highlighted, have already been described as essential 
for ASFV entry in susceptible cells [45], giving consist-
ency and validity to our results. Clathrin-mediated endo-
cytosis, a strategy used by many viruses for cell entry [46], 
is commonly activated during both attenuated and viru-
lent ASFV infection (Table 6) from day 1 pi with E75 and 
from day 3 pi with the E75CV1 strain, coinciding with the 
differential kinetics of ASFV in vivo replication observed 
for both strains [16]. The differential expression of sev-
eral other proteins also involved in cytoskeleton forma-
tion it is worthy to be discussed. Thereby, the Rho GTPase 
family is also involved in the regulation of microtubules 
during dynein-mediated capsid transport of herpes virus 
associated Kaposi’s sarcoma [47], a pathway also required 
for ASFV entry, morphogenesis and exit from the infected 
cells [31, 44]. The inhibition of RhoGTPases by RhoGDI 
by attenuated isolate might have a negative effect in all 
these processes thus impairing the in  vivo transmission 
of E75CV1. Conversely, the down-expression of RhoGDI 
at 7 dpi, might contribute to the successful systemic dis-
semination of E75. Also, the results observed with RP/EB 
microtubule-associated protein (which negatively regu-
lates microtubule formation) point in this direction. Thus, 
interestingly, in our study this protein is down-regulated 
at 1 dpi with both virus (which would facilitate the forma-
tion of the microtubules and therefore traffic virus at the 
onset of infection) but over-expressed to 3 dpi only with 
attenuated isolate (inhibiting the formation of the micro-
tubules and thus the transport of the attenuated isolate).
A chapter apart deserves discussing the sub-expression 
found at early times post-infection (day 1 and 3 pi) with 
both viruses, of several of the 7 isoforms of 14-3-3 protein, 
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a novel finding for ASFV. 14-3-3 interactome studies have 
demonstrated that 14-3-3 proteins participate in many 
events associated with infection in other viruses [48], 
mainly activated by dsRNA. The downregulation observed 
for both E75CV1 and E75 in vivo might reflect the need 
of ASFV to evade the innate immune responses triggered 
by 14-3-3, including the activation of TNF and NFκB sig-
nalling or any other antimicrobial responses triggered by 
activating the TLR-14-3-3 pathways [49]. While 14-3-3 
has been strongly associated with the innate immunity 
activated in response to dsRNA [50], its negative effect 
on virus morphogenesis [51], and ASFV-exit from the 
cell, [52], have been also described. On the other hand, an 
important function of 14-3-3 proteins is to inhibit apop-
tosis [53] and downregulation of 14-3-3 might also have a 
direct effect on the G2/M DNA damage checkpoint regu-
lation [54], a pathway that prevents cells with damaged 
DNA entering the M phase of cell division before repair-
ing. So, a defective G2/M checkpoint leads DNA damaged 
cells to apoptosis [55]. Curiously enough, E75CV1 down-
regulates the G2/M cell cycle control checkpoint both at 
day 1 and 3 pi, while E75 does it at day 3 pi (Table 6) as 
described for other viruses [56]. The concomitant down-
regulation of the G2/M DNA damage checkpoint and 
14-3-3 observed might contribute to differentially activate 
the apoptosis of the infected cells, perhaps contributing 
to the deficient in vivo dissemination of E75CV1 [7]. All 
together, these results seem to reflect a very complex reg-
ulation of apoptosis during ASFV infection, as has been 
previously postulated [57]. These results complement pre-
vious work demonstrating the effect of DNA damage and 
apoptosis in ASFV-in vitro replication [58], confirming 
the role that 14-3-3 play during apoptosis inhibition [53], 
as has been demonstrated for other viruses [59]. Studies 
to confirm the relevance of 14-3-3 in this inhibition might 
help to design novel antiviral strategies.
The last part of the discussion will be dedicated to the 
results obtained with samples harvested at day 31 after 
the infection with E75CV1, that might be very useful to 
understand the intrinsic mechanisms involved in pro-
tection against E75-virulent challenge. As expected, the 
proteomic analysis performed with these samples seem 
to confirm the key relevance that both antibodies [4] and 
CD8 T-cells [15, 60], play in protection against ASFV. 
The immunoglobulin (Ig) isoforms detected could play 
a dual role participating either in ASFV-antibody medi-
ated protection [4], or also in the formation of immune 
complexes found in chronically ASFV infected pigs [15]. 
PMSA1 and PMS6 are involved in swine leukocyte anti-
gen class I (SLAI) presentation and CD8-T cell induction 
but also have endoribonuclease activity, playing impor-
tant defensive roles in response to external stimuli [61]. 
The up-regulation of other proteins with implication 
in the antigenic presentation, such as retinol-binding 
protein 4 (responsible for retinol transport) and galac-
tose mutarotase (GALM) are also of interest. Retinol is 
a potent regulator of B-cell receptor function and B-cell 
activation [62] and regulates GALM gene expression, 
which could have an important role in cell adhesion and 
antigen presentation [63]. Other components of the B 
cell response were upregulated, including members of Ig 
family, proteins implicated in antigenic processing and 
SLAI antigen presentation (as proteasome subunits), cal-
reticulin or serpin. Calreticulin (CRT) is a  Ca2+-binding 
protein involved in more than 40 functions, including 
the unfolded protein response (UPR) and antigen pres-
entation. Interestingly, CRT has been found upregulated 
in vitro as part of endoplasmic reticulum (ER) stress and 
the UPR provoked by ASFV in infected cell [64]. UPR 
is a antiviral mechanism, against which many viruses 
develop multiple strategies [65] and on the other hand, 
CRT transport antigens to the ER, facilitating antigen 
presentation in association with the major histocompat-
ibility complex class I (MHC-I) molecules to elicit pep-
tide-specific  CD8+ T cell responses [66]. In accordance 
with the latter, several other proteins involved in antigen 
presentation and T-cell activation have been found up-
regulated at day 31 pi with E75CV1, including SERPINB9 
and proteasomal subunits. Serpin B anti-proteases have 
been defined as regulators of the immune response up-
regulated during several virus infections, including HIV 
[67] and Epstein–Barr virus infection [68]. SERPINB9 
has been shown to be involved in protection of antigen 
presenting cells, enhancing T cell activation and immune 
response [68], including in IFN-γ production and anti-
viral cytopathic responses [69] and survival of  CD8+ 
memory T cells [70]. The proteomic data obtained with 
samples from E75CV1-recoverd pigs (31 dpi) perfectly 
fits with the increasing evidence that Th1 and specific 
CD8 T-cells play in protection [3], including our previous 
data using this same ASFV-infection model [16]. Alto-
gether, our results could indicate that the over-expression 
of CRT, SERPINB9 and subunits from the proteasome 
reflect the relevance that SLAI presentation and CD8 
T-cell activation play during ASFV infection, opening 
new avenues to fight the disease. Interestingly, these three 
components have already been used as genetic adjuvants 
to improve the specific immunity against several patho-
gens [68]. We are currently extending our studies to the 
field of ASFV vaccinology. Thus, today we know that tar-
geting antigens to the proteasome improves the protec-
tion against ASFV even in the absence of antibodies [14, 
60]. The knowledge gained here opens new avenues to 
improve these strategies in the near future.
In conclusion, the data presented here are the first to 
compare kinetics of protein expression profiles from pigs 
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infected by homologous virulent or attenuated strains 
of ASFV, through a proteomics approach coupled with 
a large-scale in vivo infection, in order to allow the gen-
eration of advances in our understanding about the pig 
immune response to virus and pathogenesis of ASF over 
time. Our results confirm a differential interaction with 
the immune system for both viruses. Thus, GLN from 
E75CV1 infected pigs showed the largest number of dif-
ferentially upregulated proteins as early as 1 dpi, many 
of them involved in the activation of different innate 
immune pathways, including autoantigens. In addition to 
a lower replication efficiency at early time post-infection 
by attenuated isolated, the induction of specific anti-
body and T-cell responses at 31 dpi, were observed, once 
E75CV1 has been cleared. We believe that the increased 
information yielded by this global approach could 
improve our knowledge about the major point underly-
ing host–pathogen interactions and might be the impor-
tant for the development of an efficacious ASF vaccine.
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